The document discusses the role of hospital pharmacists in managing medical gases in Italy. It outlines the regulatory requirements that designate pharmacists as responsible for overseeing medical gases, which include therapeutic oxygen as well as other gases used for various medical purposes. The document then describes a practical experience where the author, as a hospital pharmacist, successfully managed medical gases at a hospital from 2013 to 2018 in accordance with quality, cost, risk, and time standards. It concludes that while pharmacists may not be engineers, the role requires strong chemistry and management skills to adequately oversee complex hospital medical gas systems, as mandated by current regulations.
The document discusses the International Council for Harmonization (ICH), a joint initiative between regulatory authorities and pharmaceutical industries from Europe, Japan, and the US to harmonize technical requirements for pharmaceutical registration. The goals of ICH are to ensure safety, quality and efficacy of medicines, harmonize technical requirements, and develop drugs in an efficient and cost-effective way. ICH has produced numerous guidelines on quality, safety, efficacy and multidisciplinary topics to harmonize regulatory standards across regions.
The document discusses the International Council for Harmonisation of Technical Requirements for Pharmaceuticals for Human Use (ICH). ICH aims to harmonize technical requirements for pharmaceutical registration among regions to ensure safety, quality and efficacy while promoting efficiency. It brings together regulators and industry from the EU, Japan and US to establish unified guidelines. The document outlines several ICH guidelines related to quality, efficacy, safety, and multidisciplinary topics. It provides details on quality guidelines regarding stability testing, analytical validation, impurities and other pharmaceutical development and manufacturing standards.
The document discusses the International Council for Harmonization of Technical Requirements for Pharmaceuticals for Human Use (ICH) guidelines. It provides an introduction to ICH, the need for harmonization, the origin and evolution of ICH, its objectives and members. It then describes the process of ICH harmonization and provides examples of ICH guidelines related to quality, safety, efficacy, and multidisciplinary topics. The quality guidelines address stability testing, impurities thresholds, and good manufacturing practices.
This document summarizes the role of clinical pharmacists in diagnostic imaging procedures that utilize contrast agents or radiopharmaceuticals. It discusses how clinical pharmacists are experts in drug management and can help ensure proper use and monitoring of contrast agents and radiopharmaceuticals. The document also reviews literature showing that involvement of clinical pharmacists in imaging procedures can improve patient outcomes and safety while reducing costs.
The document discusses the role of hospital pharmacists in managing medical gases in Italy. It outlines the regulatory requirements that designate pharmacists as responsible for overseeing medical gases, which include therapeutic oxygen as well as other gases used for various medical purposes. The document then describes a practical experience where the author, as a hospital pharmacist, successfully managed medical gases at a hospital from 2013 to 2018 in accordance with quality, cost, risk, and time standards. It concludes that while pharmacists may not be engineers, the role requires strong chemistry and management skills to adequately oversee complex hospital medical gas systems, as mandated by current regulations.
The document discusses the International Council for Harmonization (ICH), a joint initiative between regulatory authorities and pharmaceutical industries from Europe, Japan, and the US to harmonize technical requirements for pharmaceutical registration. The goals of ICH are to ensure safety, quality and efficacy of medicines, harmonize technical requirements, and develop drugs in an efficient and cost-effective way. ICH has produced numerous guidelines on quality, safety, efficacy and multidisciplinary topics to harmonize regulatory standards across regions.
The document discusses the International Council for Harmonisation of Technical Requirements for Pharmaceuticals for Human Use (ICH). ICH aims to harmonize technical requirements for pharmaceutical registration among regions to ensure safety, quality and efficacy while promoting efficiency. It brings together regulators and industry from the EU, Japan and US to establish unified guidelines. The document outlines several ICH guidelines related to quality, efficacy, safety, and multidisciplinary topics. It provides details on quality guidelines regarding stability testing, analytical validation, impurities and other pharmaceutical development and manufacturing standards.
The document discusses the International Council for Harmonization of Technical Requirements for Pharmaceuticals for Human Use (ICH) guidelines. It provides an introduction to ICH, the need for harmonization, the origin and evolution of ICH, its objectives and members. It then describes the process of ICH harmonization and provides examples of ICH guidelines related to quality, safety, efficacy, and multidisciplinary topics. The quality guidelines address stability testing, impurities thresholds, and good manufacturing practices.
This document summarizes the role of clinical pharmacists in diagnostic imaging procedures that utilize contrast agents or radiopharmaceuticals. It discusses how clinical pharmacists are experts in drug management and can help ensure proper use and monitoring of contrast agents and radiopharmaceuticals. The document also reviews literature showing that involvement of clinical pharmacists in imaging procedures can improve patient outcomes and safety while reducing costs.
This document summarizes a book on graphene and its derivatives in mRNA vaccine manufacturing and toxicology. It discusses graphene's physicochemical properties and potential use as carriers or adjuvants in COVID-19 vaccines. It notes recent evidence from microscope analysis of vaccine vials that found contaminants correlating with reported adverse reactions. The authors call for further investigation of manufacturing processes and independent laboratory testing of vaccine vials to verify the absence of graphene derivatives and clarify purity.
ICH GUIDELINES Q S E M & REGULATORY REQUIREMENTS OF EU, MHRA, TGA & ROW CO...RushikeshPalkar1
The document discusses the International Conference on Harmonization (ICH), an initiative to harmonize technical requirements for pharmaceutical registration. It describes ICH's mission to reduce redundant testing, outlines its structure and members, and explains the guidelines and regulatory requirements of various countries and regions, including the EU, MHRA, TGA, and rest of world.
This document summarizes the role of hospital pharmacists in managing medicinal gases in hospitals based on a practical experience in an advanced country. Hospital pharmacists are responsible for the logistics and quality control of medicinal gases, which are classified as drugs or medical devices according to European regulations. They ensure proper storage, distribution, and use of gases like oxygen, nitrous oxide, carbon dioxide, and others used for therapies, diagnostics, and research. Pharmacists work with a multidisciplinary team on gas management procedures, safety, cost containment, and training regarding therapeutic gases. Their roles include quality testing, vigilance reporting, emergency planning, and participating in procurement and accreditation processes related to medicinal gases.
This document summarizes the role of hospital pharmacists in managing medicinal gases in hospitals based on a practical experience in an advanced country. Hospital pharmacists are responsible for the logistics and quality control of medicinal gases, which are classified as drugs or medical devices according to European regulations. They oversee the production, storage, distribution, and use of oxygen, nitrous oxide, carbon dioxide, and other gases used in therapies and diagnostics. Pharmacists also collaborate with other professionals on safety procedures, staff training, quality testing, emergency preparedness, and documentation regarding medicinal gas management.
The document outlines a pharmacovigilance workshop, including definitions of pharmacovigilance, the need for monitoring drug safety post-approval, and the pharmacovigilance system process of collecting, evaluating and taking action on adverse drug reactions. The workshop introduction discusses educational activities in Croatia to increase healthcare professional reporting of adverse reactions.
The International Pharmaceutical Federation (FIP) first adopted the guidelines for Good Pharmaceutical Practice in 1993. These guidelines were developed as a reference to be used by national pharmaceutical organisations, governments, and international pharmaceutical organizations to set up nationally accepted standards of Good Pharmacy Practice.
A revised version of this document was endorsed by WHO in 1997 and subsequently approved by the FIP Council in 1997.
In 2011, FIP and WHO adopted an updated version of Good Pharmacy Practice entitled "Joint FIP/WHO guidelines on good pharmacy practice: standards for quality of pharmacy services".
Full reference: Joint FIP/WHO guidelines on good pharmacy practice: standards for quality of pharmacy services. WHO Technical Report Series, No. 961, 2011. Geneva: World Health Organization, 2011.
In this document, the aim of pharmacy practice aim is defined as to "contribute to health improvement and to help patients with health problems to make the best use of their medicines."
GPP is defined as "the practice of pharmacy that responds to the needs of the people who use the pharmacists’ services to provide optimal, evidence-based care. To support this practice it is essential that there be an established national framework of quality standards and guidelines."
The 2011 GPP document underlines the requirements of Good Pharmacy Practice and how to set standards required for GPP, (which also imply a quality management framework and a strategic plan for developing services).
GPP are organised around 4 major roles for pharmacists
Role 1: Prepare, obtain, store, secure, distribute, administer, dispense and dispose of medical products
Role 2: Provide effective medication therapy management
Role 3: Maintain and improve professional performance
Role 4: Contribute to improve effectiveness of the health-care system and public health
Each function is structured in several roles, and for each role, a list of minimum national standards to be established have been set.
WHO/FIP GPP should serve as a guidance document for the development of specific standards of GPP at national levels by national pharmacists associations and other related stakeholders.
When establishing minimum standards on GPP, it is important to define the roles played by pharmacists, as expected
by patients and society. Secondly, relevant functions for which pharmacists have direct responsibility and accountability need to be determined within each role. Thirdly, minimum national standards should then be established, based upon the need to demonstrate competency in a set of activities supporting each function and role.
Source of info: http://www.fip.org/good_pharmacy_practice
This document discusses regulatory affairs and the current regulatory framework in Europe regarding new legislation and its relevance to stakeholders in drug development. It provides an overview of regulatory affairs as integral to drug development, principles of good practices (GxP) including good laboratory practice (GLP), good clinical practice (GCP), and good manufacturing practice (GMP), and new developments currently happening in Europe. Key aspects of regulatory dossiers like common technical documents (CTDs) and electronic common technical documents (eCTDs) are explained. The roles and responsibilities of regulatory professionals are also outlined.
The International Conference on Harmonization (ICH) aims to harmonize technical requirements for pharmaceutical registration across Europe, Japan, and the United States to reduce duplication of testing and delays in availability of new medicines. ICH addresses quality, safety, efficacy, and multidisciplinary topics through guidelines developed by experts from regulatory authorities and the pharmaceutical industry in the three regions. The objectives of ICH harmonization are more efficient use of resources and protection of public health while eliminating unnecessary delays in the global development and availability of new medicines.
This document provides an overview of the scope of pharmacology. It discusses the history and evolution of pharmacology from materia medica and early pharmacy to its modern academic, industrial and research applications. Key areas of pharmacology discussed include drug development process, clinical pharmacology, special domains like pharmacovigilance, pharmacoeconomics and emerging areas like pharmacogenomics. The document outlines the past, present and future scope of pharmacology and how it aims to advance human health through rational and safe use of medicines.
Thông báo về chuyển ngữ sang tiếng Việt CSDS STABILISHA VO THI
This newsletter provides summaries of recent developments in Stabilis and stability studies:
1) Stabilis has added Vietnamese as its 29th language, allowing more users in Vietnam to access the database.
2) Recent conferences included posters on compatibility studies and stability studies of drugs like azacitidine, phenylephrine, and naloxone.
3) A new textbook on practical pharmaceutics includes a chapter on stability and is now available for order.
This document provides a summary of ICH (International Conference on Harmonisation) guidelines. It discusses the purpose of ICH in harmonizing technical requirements for pharmaceutical registration across regions to ensure safety and efficacy. ICH guidelines cover topics like nonclinical safety studies, clinical safety data, stability testing, and electronic submission of safety reports. The document outlines the structure of ICH including its steering committee and working groups and describes how guidelines are developed and can be used by regulators and industry globally.
The document presents an overview of ICH guidelines. It discusses that ICH was created in 1990 to harmonize pharmaceutical regulations between Europe, Japan, and the US. ICH has developed over 45 guidelines divided into quality, safety, efficacy, and multidisciplinary categories. The quality guidelines address chemical and pharmaceutical quality assurance. The safety guidelines cover preclinical safety testing. The efficacy guidelines relate to clinical trial design, conduct, and reporting. The multidisciplinary guidelines cover topics that do not fit uniquely into the other categories. In summary, the document provides a high-level introduction to the structure and guidelines of the International Council for Harmonisation.
The document summarizes updates from the Pharmacy and Therapeutics Committee, including approval of new non-formulary and formulary drugs. Fingolimod and teriflunomide were approved as non-formulary drugs for treating multiple sclerosis. Anidulafungin was approved as a formulary antifungal drug. The document also provides information on pharmacy services, guidelines, new medications added to the formulary, and efforts to minimize medication errors.
1) Hospital pharmacists play an important role in managing medical gas systems in hospitals. They contribute to ensuring proper pharmacological therapies using gases, prevent emergencies, and ensure quality, safety, and cost containment.
2) Pharmacists' competencies in medicinal chemistry and management are crucial for their role in overseeing medical gas logistics and distribution, quality control testing, staff training, and emergency procedures.
3) Pharmacists are responsible for regulatory compliance, quality assurance of gases from production and distribution systems, proper storage of tanks, and documentation according to various standards and norms.
1) Hospital pharmacists play an important role in managing medical gas systems in hospitals. They contribute to ensuring proper pharmacological therapies using gases, prevent emergencies, and ensure quality, safety, and cost containment.
2) Pharmacists' competencies in medicinal chemistry and management are key to their role in overseeing medical gas logistics and distribution, quality control testing, staff training, and emergency procedures in compliance with regulations.
3) As the responsible parties for medical gases, pharmacists collaborate with various teams to write procedures, manage risks, store documentation, and provide clinical pharmacy services regarding gases' use in hospitals.
Key importance of ICH guideline, a brief summary on the international guidelines for new drug development.
Specifically for regulatory affairs student of MPharm
The document provides a history of pharmaceutical quality and regulations, beginning with tragic events in the early 20th century that led to the first drug safety laws. It describes key milestones in GMP development and implementation, from the 1938 FD&C Act to modern ICH guidelines. The current pharmaceutical quality system aims to ensure safety, efficacy and conformity through elements like quality control, assurance programs, documentation standards, and change management processes across the product lifecycle.
this presentation mainly based on the regulatory aspects of packaging and gives all significance about packaging regulations,help in pharma or biotechnology .
This document provides information about an investigational drug project submitted by Tashi Choezom for her B.Pharmacy degree. It discusses the various phases of drug development including drug discovery, characterization of investigational drugs, formulation, pharmacokinetics, preclinical toxicity studies, the Investigational New Drug application process, bioanalytical and clinical trials. The project is supervised by Kriti Bhadoria and submitted to Veer Madho Singh Bhandari Uttarakhand Technical University.
This document summarizes a book on graphene and its derivatives in mRNA vaccine manufacturing and toxicology. It discusses graphene's physicochemical properties and potential use as carriers or adjuvants in COVID-19 vaccines. It notes recent evidence from microscope analysis of vaccine vials that found contaminants correlating with reported adverse reactions. The authors call for further investigation of manufacturing processes and independent laboratory testing of vaccine vials to verify the absence of graphene derivatives and clarify purity.
ICH GUIDELINES Q S E M & REGULATORY REQUIREMENTS OF EU, MHRA, TGA & ROW CO...RushikeshPalkar1
The document discusses the International Conference on Harmonization (ICH), an initiative to harmonize technical requirements for pharmaceutical registration. It describes ICH's mission to reduce redundant testing, outlines its structure and members, and explains the guidelines and regulatory requirements of various countries and regions, including the EU, MHRA, TGA, and rest of world.
This document summarizes the role of hospital pharmacists in managing medicinal gases in hospitals based on a practical experience in an advanced country. Hospital pharmacists are responsible for the logistics and quality control of medicinal gases, which are classified as drugs or medical devices according to European regulations. They ensure proper storage, distribution, and use of gases like oxygen, nitrous oxide, carbon dioxide, and others used for therapies, diagnostics, and research. Pharmacists work with a multidisciplinary team on gas management procedures, safety, cost containment, and training regarding therapeutic gases. Their roles include quality testing, vigilance reporting, emergency planning, and participating in procurement and accreditation processes related to medicinal gases.
This document summarizes the role of hospital pharmacists in managing medicinal gases in hospitals based on a practical experience in an advanced country. Hospital pharmacists are responsible for the logistics and quality control of medicinal gases, which are classified as drugs or medical devices according to European regulations. They oversee the production, storage, distribution, and use of oxygen, nitrous oxide, carbon dioxide, and other gases used in therapies and diagnostics. Pharmacists also collaborate with other professionals on safety procedures, staff training, quality testing, emergency preparedness, and documentation regarding medicinal gas management.
The document outlines a pharmacovigilance workshop, including definitions of pharmacovigilance, the need for monitoring drug safety post-approval, and the pharmacovigilance system process of collecting, evaluating and taking action on adverse drug reactions. The workshop introduction discusses educational activities in Croatia to increase healthcare professional reporting of adverse reactions.
The International Pharmaceutical Federation (FIP) first adopted the guidelines for Good Pharmaceutical Practice in 1993. These guidelines were developed as a reference to be used by national pharmaceutical organisations, governments, and international pharmaceutical organizations to set up nationally accepted standards of Good Pharmacy Practice.
A revised version of this document was endorsed by WHO in 1997 and subsequently approved by the FIP Council in 1997.
In 2011, FIP and WHO adopted an updated version of Good Pharmacy Practice entitled "Joint FIP/WHO guidelines on good pharmacy practice: standards for quality of pharmacy services".
Full reference: Joint FIP/WHO guidelines on good pharmacy practice: standards for quality of pharmacy services. WHO Technical Report Series, No. 961, 2011. Geneva: World Health Organization, 2011.
In this document, the aim of pharmacy practice aim is defined as to "contribute to health improvement and to help patients with health problems to make the best use of their medicines."
GPP is defined as "the practice of pharmacy that responds to the needs of the people who use the pharmacists’ services to provide optimal, evidence-based care. To support this practice it is essential that there be an established national framework of quality standards and guidelines."
The 2011 GPP document underlines the requirements of Good Pharmacy Practice and how to set standards required for GPP, (which also imply a quality management framework and a strategic plan for developing services).
GPP are organised around 4 major roles for pharmacists
Role 1: Prepare, obtain, store, secure, distribute, administer, dispense and dispose of medical products
Role 2: Provide effective medication therapy management
Role 3: Maintain and improve professional performance
Role 4: Contribute to improve effectiveness of the health-care system and public health
Each function is structured in several roles, and for each role, a list of minimum national standards to be established have been set.
WHO/FIP GPP should serve as a guidance document for the development of specific standards of GPP at national levels by national pharmacists associations and other related stakeholders.
When establishing minimum standards on GPP, it is important to define the roles played by pharmacists, as expected
by patients and society. Secondly, relevant functions for which pharmacists have direct responsibility and accountability need to be determined within each role. Thirdly, minimum national standards should then be established, based upon the need to demonstrate competency in a set of activities supporting each function and role.
Source of info: http://www.fip.org/good_pharmacy_practice
This document discusses regulatory affairs and the current regulatory framework in Europe regarding new legislation and its relevance to stakeholders in drug development. It provides an overview of regulatory affairs as integral to drug development, principles of good practices (GxP) including good laboratory practice (GLP), good clinical practice (GCP), and good manufacturing practice (GMP), and new developments currently happening in Europe. Key aspects of regulatory dossiers like common technical documents (CTDs) and electronic common technical documents (eCTDs) are explained. The roles and responsibilities of regulatory professionals are also outlined.
The International Conference on Harmonization (ICH) aims to harmonize technical requirements for pharmaceutical registration across Europe, Japan, and the United States to reduce duplication of testing and delays in availability of new medicines. ICH addresses quality, safety, efficacy, and multidisciplinary topics through guidelines developed by experts from regulatory authorities and the pharmaceutical industry in the three regions. The objectives of ICH harmonization are more efficient use of resources and protection of public health while eliminating unnecessary delays in the global development and availability of new medicines.
This document provides an overview of the scope of pharmacology. It discusses the history and evolution of pharmacology from materia medica and early pharmacy to its modern academic, industrial and research applications. Key areas of pharmacology discussed include drug development process, clinical pharmacology, special domains like pharmacovigilance, pharmacoeconomics and emerging areas like pharmacogenomics. The document outlines the past, present and future scope of pharmacology and how it aims to advance human health through rational and safe use of medicines.
Thông báo về chuyển ngữ sang tiếng Việt CSDS STABILISHA VO THI
This newsletter provides summaries of recent developments in Stabilis and stability studies:
1) Stabilis has added Vietnamese as its 29th language, allowing more users in Vietnam to access the database.
2) Recent conferences included posters on compatibility studies and stability studies of drugs like azacitidine, phenylephrine, and naloxone.
3) A new textbook on practical pharmaceutics includes a chapter on stability and is now available for order.
This document provides a summary of ICH (International Conference on Harmonisation) guidelines. It discusses the purpose of ICH in harmonizing technical requirements for pharmaceutical registration across regions to ensure safety and efficacy. ICH guidelines cover topics like nonclinical safety studies, clinical safety data, stability testing, and electronic submission of safety reports. The document outlines the structure of ICH including its steering committee and working groups and describes how guidelines are developed and can be used by regulators and industry globally.
The document presents an overview of ICH guidelines. It discusses that ICH was created in 1990 to harmonize pharmaceutical regulations between Europe, Japan, and the US. ICH has developed over 45 guidelines divided into quality, safety, efficacy, and multidisciplinary categories. The quality guidelines address chemical and pharmaceutical quality assurance. The safety guidelines cover preclinical safety testing. The efficacy guidelines relate to clinical trial design, conduct, and reporting. The multidisciplinary guidelines cover topics that do not fit uniquely into the other categories. In summary, the document provides a high-level introduction to the structure and guidelines of the International Council for Harmonisation.
The document summarizes updates from the Pharmacy and Therapeutics Committee, including approval of new non-formulary and formulary drugs. Fingolimod and teriflunomide were approved as non-formulary drugs for treating multiple sclerosis. Anidulafungin was approved as a formulary antifungal drug. The document also provides information on pharmacy services, guidelines, new medications added to the formulary, and efforts to minimize medication errors.
1) Hospital pharmacists play an important role in managing medical gas systems in hospitals. They contribute to ensuring proper pharmacological therapies using gases, prevent emergencies, and ensure quality, safety, and cost containment.
2) Pharmacists' competencies in medicinal chemistry and management are crucial for their role in overseeing medical gas logistics and distribution, quality control testing, staff training, and emergency procedures.
3) Pharmacists are responsible for regulatory compliance, quality assurance of gases from production and distribution systems, proper storage of tanks, and documentation according to various standards and norms.
1) Hospital pharmacists play an important role in managing medical gas systems in hospitals. They contribute to ensuring proper pharmacological therapies using gases, prevent emergencies, and ensure quality, safety, and cost containment.
2) Pharmacists' competencies in medicinal chemistry and management are key to their role in overseeing medical gas logistics and distribution, quality control testing, staff training, and emergency procedures in compliance with regulations.
3) As the responsible parties for medical gases, pharmacists collaborate with various teams to write procedures, manage risks, store documentation, and provide clinical pharmacy services regarding gases' use in hospitals.
Key importance of ICH guideline, a brief summary on the international guidelines for new drug development.
Specifically for regulatory affairs student of MPharm
The document provides a history of pharmaceutical quality and regulations, beginning with tragic events in the early 20th century that led to the first drug safety laws. It describes key milestones in GMP development and implementation, from the 1938 FD&C Act to modern ICH guidelines. The current pharmaceutical quality system aims to ensure safety, efficacy and conformity through elements like quality control, assurance programs, documentation standards, and change management processes across the product lifecycle.
this presentation mainly based on the regulatory aspects of packaging and gives all significance about packaging regulations,help in pharma or biotechnology .
This document provides information about an investigational drug project submitted by Tashi Choezom for her B.Pharmacy degree. It discusses the various phases of drug development including drug discovery, characterization of investigational drugs, formulation, pharmacokinetics, preclinical toxicity studies, the Investigational New Drug application process, bioanalytical and clinical trials. The project is supervised by Kriti Bhadoria and submitted to Veer Madho Singh Bhandari Uttarakhand Technical University.
Similar to IJNRDTH00156.pdf galenic laboratory 2024 -innovation and management (20)
Osteoporosis - Definition , Evaluation and Management .pdfJim Jacob Roy
Osteoporosis is an increasing cause of morbidity among the elderly.
In this document , a brief outline of osteoporosis is given , including the risk factors of osteoporosis fractures , the indications for testing bone mineral density and the management of osteoporosis
share - Lions, tigers, AI and health misinformation, oh my!.pptxTina Purnat
• Pitfalls and pivots needed to use AI effectively in public health
• Evidence-based strategies to address health misinformation effectively
• Building trust with communities online and offline
• Equipping health professionals to address questions, concerns and health misinformation
• Assessing risk and mitigating harm from adverse health narratives in communities, health workforce and health system
Does Over-Masturbation Contribute to Chronic Prostatitis.pptxwalterHu5
In some case, your chronic prostatitis may be related to over-masturbation. Generally, natural medicine Diuretic and Anti-inflammatory Pill can help mee get a cure.
TEST BANK For Community Health Nursing A Canadian Perspective, 5th Edition by...Donc Test
TEST BANK For Community Health Nursing A Canadian Perspective, 5th Edition by Stamler, Verified Chapters 1 - 33, Complete Newest Version Community Health Nursing A Canadian Perspective, 5th Edition by Stamler, Verified Chapters 1 - 33, Complete Newest Version Community Health Nursing A Canadian Perspective, 5th Edition by Stamler Community Health Nursing A Canadian Perspective, 5th Edition TEST BANK by Stamler Test Bank For Community Health Nursing A Canadian Perspective, 5th Edition Pdf Chapters Download Test Bank For Community Health Nursing A Canadian Perspective, 5th Edition Pdf Download Stuvia Test Bank For Community Health Nursing A Canadian Perspective, 5th Edition Study Guide Test Bank For Community Health Nursing A Canadian Perspective, 5th Edition Ebook Download Stuvia Test Bank For Community Health Nursing A Canadian Perspective, 5th Edition Questions and Answers Quizlet Test Bank For Community Health Nursing A Canadian Perspective, 5th Edition Studocu Test Bank For Community Health Nursing A Canadian Perspective, 5th Edition Quizlet Test Bank For Community Health Nursing A Canadian Perspective, 5th Edition Stuvia Community Health Nursing A Canadian Perspective, 5th Edition Pdf Chapters Download Community Health Nursing A Canadian Perspective, 5th Edition Pdf Download Course Hero Community Health Nursing A Canadian Perspective, 5th Edition Answers Quizlet Community Health Nursing A Canadian Perspective, 5th Edition Ebook Download Course hero Community Health Nursing A Canadian Perspective, 5th Edition Questions and Answers Community Health Nursing A Canadian Perspective, 5th Edition Studocu Community Health Nursing A Canadian Perspective, 5th Edition Quizlet Community Health Nursing A Canadian Perspective, 5th Edition Stuvia Community Health Nursing A Canadian Perspective, 5th Edition Test Bank Pdf Chapters Download Community Health Nursing A Canadian Perspective, 5th Edition Test Bank Pdf Download Stuvia Community Health Nursing A Canadian Perspective, 5th Edition Test Bank Study Guide Questions and Answers Community Health Nursing A Canadian Perspective, 5th Edition Test Bank Ebook Download Stuvia Community Health Nursing A Canadian Perspective, 5th Edition Test Bank Questions Quizlet Community Health Nursing A Canadian Perspective, 5th Edition Test Bank Studocu Community Health Nursing A Canadian Perspective, 5th Edition Test Bank Quizlet Community Health Nursing A Canadian Perspective, 5th Edition Test Bank Stuvia
8 Surprising Reasons To Meditate 40 Minutes A Day That Can Change Your Life.pptxHolistified Wellness
We’re talking about Vedic Meditation, a form of meditation that has been around for at least 5,000 years. Back then, the people who lived in the Indus Valley, now known as India and Pakistan, practised meditation as a fundamental part of daily life. This knowledge that has given us yoga and Ayurveda, was known as Veda, hence the name Vedic. And though there are some written records, the practice has been passed down verbally from generation to generation.
Recomendações da OMS sobre cuidados maternos e neonatais para uma experiência pós-natal positiva.
Em consonância com os ODS – Objetivos do Desenvolvimento Sustentável e a Estratégia Global para a Saúde das Mulheres, Crianças e Adolescentes, e aplicando uma abordagem baseada nos direitos humanos, os esforços de cuidados pós-natais devem expandir-se para além da cobertura e da simples sobrevivência, de modo a incluir cuidados de qualidade.
Estas diretrizes visam melhorar a qualidade dos cuidados pós-natais essenciais e de rotina prestados às mulheres e aos recém-nascidos, com o objetivo final de melhorar a saúde e o bem-estar materno e neonatal.
Uma “experiência pós-natal positiva” é um resultado importante para todas as mulheres que dão à luz e para os seus recém-nascidos, estabelecendo as bases para a melhoria da saúde e do bem-estar a curto e longo prazo. Uma experiência pós-natal positiva é definida como aquela em que as mulheres, pessoas que gestam, os recém-nascidos, os casais, os pais, os cuidadores e as famílias recebem informação consistente, garantia e apoio de profissionais de saúde motivados; e onde um sistema de saúde flexível e com recursos reconheça as necessidades das mulheres e dos bebês e respeite o seu contexto cultural.
Estas diretrizes consolidadas apresentam algumas recomendações novas e já bem fundamentadas sobre cuidados pós-natais de rotina para mulheres e neonatos que recebem cuidados no pós-parto em unidades de saúde ou na comunidade, independentemente dos recursos disponíveis.
É fornecido um conjunto abrangente de recomendações para cuidados durante o período puerperal, com ênfase nos cuidados essenciais que todas as mulheres e recém-nascidos devem receber, e com a devida atenção à qualidade dos cuidados; isto é, a entrega e a experiência do cuidado recebido. Estas diretrizes atualizam e ampliam as recomendações da OMS de 2014 sobre cuidados pós-natais da mãe e do recém-nascido e complementam as atuais diretrizes da OMS sobre a gestão de complicações pós-natais.
O estabelecimento da amamentação e o manejo das principais intercorrências é contemplada.
Recomendamos muito.
Vamos discutir essas recomendações no nosso curso de pós-graduação em Aleitamento no Instituto Ciclos.
Esta publicação só está disponível em inglês até o momento.
Prof. Marcus Renato de Carvalho
www.agostodourado.com
NVBDCP.pptx Nation vector borne disease control programSapna Thakur
NVBDCP was launched in 2003-2004 . Vector-Borne Disease: Disease that results from an infection transmitted to humans and other animals by blood-feeding arthropods, such as mosquitoes, ticks, and fleas. Examples of vector-borne diseases include Dengue fever, West Nile Virus, Lyme disease, and malaria.
Promoting Wellbeing - Applied Social Psychology - Psychology SuperNotesPsychoTech Services
A proprietary approach developed by bringing together the best of learning theories from Psychology, design principles from the world of visualization, and pedagogical methods from over a decade of training experience, that enables you to: Learn better, faster!
Histololgy of Female Reproductive System.pptxAyeshaZaid1
Dive into an in-depth exploration of the histological structure of female reproductive system with this comprehensive lecture. Presented by Dr. Ayesha Irfan, Assistant Professor of Anatomy, this presentation covers the Gross anatomy and functional histology of the female reproductive organs. Ideal for students, educators, and anyone interested in medical science, this lecture provides clear explanations, detailed diagrams, and valuable insights into female reproductive system. Enhance your knowledge and understanding of this essential aspect of human biology.
Here is the updated list of Top Best Ayurvedic medicine for Gas and Indigestion and those are Gas-O-Go Syp for Dyspepsia | Lavizyme Syrup for Acidity | Yumzyme Hepatoprotective Capsules etc
